Senior insider sale
EVP & GENERAL COUNSEL at UNITED THERAPEUTICS CORP — senior position signals high conviction
$32.22M
66.20K shares
What this filing means
MAHON PAUL A plans to sell 66.20K shares of UNITED THERAPEUTICS CORP valued at approximately $32.22M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/19/2026ACC: 0001950047-26-001501
Officer· EVP & GENERAL COUNSEL
Since Mar 2026
66.20K
Shares to sell
$32.22M
Approx. market value
8.30K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Stock Options Exercise
Cash
2/19/2026
8.30KTotal acquired8.30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/19/2026 | Stock Options Exercise Cash | 8.30K | — |
| Total | 8.30K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
8.30K
Market value
$4.01M
2/5/2026
—Completed
Units to sell
8.30K
Market value
$3.90M
1/15/2026
—Completed
Units to sell
8.30K
Market value
$4.03M
1/2/2026
—Completed
Units to sell
11K
Market value
$5.64M
12/24/2025
—Completed
Units to sell
11K
Market value
$5.33M
12/11/2025
—Completed
Units to sell
11K
Market value
$5.35M
11/26/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.30K
Market value
$3.95M
2/19/2026
Total
Units
66.20K
Value
$32.22M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/5/2026 | 8.30K | $4.01M | — | Completed |
1/15/2026 | 8.30K | $3.90M | — | Completed |
1/2/2026 | 8.30K | $4.03M | — | Completed |
12/24/2025 | 11K | $5.64M | — | Completed |
12/11/2025 | 11K | $5.33M | — | Completed |
11/26/2025 | 11K | $5.35M | — | Completed |
| Planned — Approximate Date | ||||
2/19/2026 | 8.30K | $3.95M | NASDAQ | Planned |
| Total | 66.20K | $32.22M | ||